Coya Therapeutics (COYA) Accumulated Depreciation & Amortization (2022 - 2024)
Coya Therapeutics' Accumulated Depreciation & Amortization history spans 3 years, with the latest figure at $98216.0 for Q4 2024.
- For Q4 2024, Accumulated Depreciation & Amortization rose 38.62% year-over-year to $98216.0; the TTM value through Dec 2024 reached $98216.0, up 38.62%, while the annual FY2024 figure was $98216.0, 38.62% up from the prior year.
- Accumulated Depreciation & Amortization for Q4 2024 was $98216.0 at Coya Therapeutics, up from $70855.0 in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $98216.0 in Q4 2024 and bottomed at $43494.0 in Q4 2022.
- The 3-year median for Accumulated Depreciation & Amortization is $70855.0 (2023), against an average of $70855.0.
- The largest annual shift saw Accumulated Depreciation & Amortization surged 62.91% in 2023 before it surged 38.62% in 2024.
- A 3-year view of Accumulated Depreciation & Amortization shows it stood at $43494.0 in 2022, then skyrocketed by 62.91% to $70855.0 in 2023, then skyrocketed by 38.62% to $98216.0 in 2024.
- Per Business Quant, the three most recent readings for COYA's Accumulated Depreciation & Amortization are $98216.0 (Q4 2024), $70855.0 (Q4 2023), and $43494.0 (Q4 2022).